Literature DB >> 15770175

Disc related cytokines inhibit axonal outgrowth from dorsal root ganglion cells in vitro.

Karin Larsson1, Björn Rydevik, Kjell Olmarker.   

Abstract

STUDY
DESIGN: Application of nucleus pulposus and disc related cytokines in vitro on cultured dorsal root ganglion (DRG) cells.
OBJECTIVES: To study if tumor necrosis factor (TNF) and interleukin-1beta (IL-1beta) may induce similar inhibition of axonal outgrowth from cultured DRG cells as application of nucleus pulposus and to compare a new assessment method to previous data. SUMMARY OF BACKGROUND DATA: Pro-inflammatory cytokines related to the intervertebral disc have been suggested to affect adversely neurons following local application, with implications for the nucleus pulposus-induced nerve injury seen in various studies. Nucleus pulposus is known to inhibit axonal outgrowth from cultured DRG cells, thereby indicating a neurotoxic potential. The mechanisms were not understood, but it was suspected that the effect was mediated by pro-inflammatory cytokines produced by the nucleus pulposus.
METHODS: DRG were harvested from newborn rats and put in culture. The axonal outgrowth was determined 24 hours after starting the culture. Twenty-four hours after exposing the cultured cells to nucleus pulposus, frozen nucleus pulposus, TNF, or IL-1beta, the axonal outgrowth was reassessed, and the outgrowth during the exposure time was calculated.
RESULTS: Nucleus pulposus clearly reduced the axonal outgrowth. Also, application of TNF and IL-1beta reduced the outgrowth but not as pronounced as the nucleus pulposus. Frozen nucleus pulposus had no effects on the outgrowth. Overall, the data were similar regarding frozen and nonfrozen nucleus pulposus compared to a previous study.
CONCLUSIONS: It was evident that the 2 studied cytokines inhibited the outgrowth of axons from cultured DRG cells, thus suggesting a neurotoxic potential. However, the inhibition was not as pronounced as for nucleus pulposus. These data may increase our understanding for cytokine induced nerve injury, with implications for future treatment strategies for such conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770175     DOI: 10.1097/01.brs.0000155410.48700.9e

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Immediate anti-tumor necrosis factor-alpha (etanercept) therapy enhances axonal regeneration after sciatic nerve crush.

Authors:  Kinshi Kato; Huaqing Liu; Shin-ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  J Neurosci Res       Date:  2010-02-01       Impact factor: 4.164

2.  Etanercept Prevents Histopathological Damage after Spinal Cord Injury in Rats.

Authors:  Askin Esen Hasturk; Cagdas Baran; Erdal Resit Yilmaz; Murat Arikan; Guray Togral; Nazli Hayirli; Berrin Imge Erguder; Oya Evirgen
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

3.  Microglia-derived IL-1β contributes to axon development disorders and synaptic deficit through p38-MAPK signal pathway in septic neonatal rats.

Authors:  Qianpeng Han; Qiongyu Lin; Peixian Huang; Mengmeng Chen; Xin Hu; Hui Fu; Shaoru He; Fengcai Shen; Hongke Zeng; Yiyu Deng
Journal:  J Neuroinflammation       Date:  2017-03-14       Impact factor: 8.322

4.  Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile.

Authors:  Christine Lyn Le Maitre; Judith Alison Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

5.  Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain Injury in Rats: Ultrastructural, Pathological, and Biochemical Analyses.

Authors:  Askin Esen Hasturk; Emre Cemal Gokce; Erdal Resit Yilmaz; Bahriye Horasanli; Oya Evirgen; Nazli Hayirli; Hilal Gokturk; Imge Erguder; Belgin Can
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.